-65.7%
MRNA vs GH
+20.8%
-86.5%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -1.0% | +6.4% | +5.7% |
| 7D | -1.1% | -2.5% | +1.4% | -0.3% |
| 30D | +126.1% | -4.7% | +130.8% | +129.8% |
| 3M | +190.0% | +20.2% | +169.8% | +175.1% |
| 6M | +157.2% | +78.8% | +78.4% | +115.8% |
| YTD | +388.2% | +54.1% | +334.1% | +325.6% |
| 1Y | +467.0% | +177.1% | +290.0% | +313.4% |
| 3Y | +36.1% | +371.6% | -335.5% | -21.8% |
| All | -65.7% | +20.8% | -86.5% | -67.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GH.
Daily Out/Under-Performance
Portfolio return minus GH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling